Genezen

Indianapolis, United States

Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services.

$18.5M raised

Nov 2023

Venture - Series Unknown

Top Investors

Ampersand Capital Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Genezen raised?

Genezen has raised $18.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.

Who are Genezen's investors?

Genezen's investors include Ampersand Capital Partners.

Where is Genezen headquartered?

Genezen is headquartered in Indianapolis, United States.

What does Genezen do?

Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services.

What stage is Genezen at?

Genezen is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 2, 2023.

MLA

"Genezen — Funding & Investors." VCBacked, November 2, 2023, https://www.vcbacked.co/company/genezen. Accessed June 13, 2026.

APA

VCBacked. (2023). Genezen — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/genezen

Wikipedia (cite web)

{{cite web |title=Genezen — Funding & Investors |url=https://www.vcbacked.co/company/genezen |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 2, 2023.